News - IMSDA

CDSCO Launches Major Overhaul: Outsourcing GMP Audits and Building 1500-Expert Scientific Cadre

Post published:May 26, 2026
Post category:News

India's Central Drugs Standard Control Organisation (CDSCO) is embarking on the most significant regulatory restructuring in its history. In a move designed to strengthen pharmaceutical quality oversight and align with…

How to Verify the Quality of Indian Generic Medicines: A Practical Guide for International Buyers

Post published:May 25, 2026
Post category:Knowledge

India supplies approximately 20% of the world's generic medicines by volume, making it the largest provider of affordable pharmaceuticals globally. However, for international buyers — whether patients sourcing personal medication…

India Supplies 20% of Global Generic Medicines, GTRI Confirms IP Rules WTO-Compliant

Post published:May 24, 2026
Post category:News

New Delhi, May 2026 — India now supplies nearly 20% of the world’s generic medicines, according to a comprehensive report from the Global Trade Research Initiative (GTRI). The report, released…

Understanding WHO-GMP Certification and India’s Revised Schedule M: A Buyer’s Guide to Quality Indian Generics

Post published:May 23, 2026
Post category:Knowledge

When sourcing generic medicines from India, one term appears repeatedly in regulatory documents and product listings: WHO-GMP certified. But what does this certification actually mean? How does it compare to…